Clinical Research

Site Selection Solutions Using Patient Insights for Rare Disease Trials

February 20, 2026
Clinical Trial News

Bepirovirsen Shows Promise in Phase III for Chronic Hepatitis B

Maximizing Value in Early-Phase Oncology Trials: Innovative Endpoints for Early Insights

February 25, 2026
Biotech News

FDA Clarifies CMC Flexibility for Cell and Gene Therapies

Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know

February 26, 2026

Accelerate Your Study: Harnessing AI and Automation for Rapid Study Start-up

March 04, 2026
Biotech Blogs

Top Clinical Trials to Watch in 2026: What’s Coming in Alzheimer’s, ALS and Gene Editing
Blogs

Precision Oncology, Biomarker Testing and Clinical Innovation in NSCLC

How to Reduce Eligibility Risk and Prevent Protocol Deviations

January 28, 2026

How Community-Based Trials Are Delivering Results: Investigator and Site Perspectives

February 19, 2026
Biotech Blogs

ADCs in Oncology Clinical Research: Innovation in Precision and Trial Design
Biotech Blogs

Advancing Real-World Evidence in Obstructive Hypertrophic Cardiomyopathy
Clinical Trial News

Aleniglipron Moves Toward Phase III as Structure Therapeutics Advances Oral GLP-1 Obesity Program
Blogs

How Medtronic’s Global Heart Failure Trial Explores Personalized Pacing for HFpEF
Life Science Spotlight

What Are the Key Considerations for Overcoming Challenges in IPF and Other Rare Respiratory Disease Clinical Trials?
Biotech News

FDA Qualifies First AI Drug Development Tool, Will Support Histology Assessment in MASH Trials